Money Talk - Markets, Finance & Economy

10/23/2025

Can you guess which country is the world’s largest economy — and which one is growing the fastest?

If you guessed the U.S. and India, you’re right. The U.S. still leads the world with a projected $31.8 trillion GDP, nearly matching the combined size of China, Germany, and India. Meanwhile, India has secured its spot as the fastest-growing major economy, solidly ahead of Japan.

Globally, growth is slowing, trade is fragmenting, and risks are rising — yet the world economy continues to adapt and evolve.

Read the full analysis here
https://zurl.co/FpOJg

https://zurl.co/FpOJg

At 124 Trillion overall, the global leaderboard has shifted a bit in 2026 — but the dynamics beneath the surface are interesting. The United States remains firmly in first place with a projected $31.8 trillion GDP, nearly matching the combined size of China, Germany, and India. A strong labor mark...

09/16/2025

📊 Stocks vs. Real Estate: Which really builds more wealth?
Many people point to real estate fortunes—but often overlook the hidden costs, illiquidity, and the fact that most success stories come from running a business, not a passive investment. By contrast, the S&P 500 has historically compounded at a faster clip, with less friction.
👉 Read our full breakdown here: The Wealth Showdown: Stocks vs. Real Estate https://zurl.co/WeKSz

Your neighbor swears by property, your coworker swears by stocks—so who’s actually right?            Veda Financial | Sep

09/11/2025

Exploring AI in Healthcare, Finance & Beyond

The Women’s Initiative Network (WIN), founded to connect and empower professional women, hosted an engaging session in Irvine on the fast-evolving world of AI. Organized by Shaku Nitturkar, the meeting featured two expert speakers who shared their insights on how artificial intelligence is shaping our future.

Sonalee Tambat (Alcon) introduced the concept of digital twins—virtual replicas of physical systems—originally used in space missions and now transforming industries like healthcare and automotive. She highlighted how digital twins are being applied in personalized medicine and ophthalmology, from simulating drug delivery to developing surgical decision-support tools. Sonalee also emphasized the critical role of data validation, cybersecurity, and human oversight in ensuring that AI-driven innovations deliver safe and effective results.

Neena Sathi (AI educator and consultant) took us through the evolution of AI—from rule-based systems, to machine learning, and now to large language models (LLMs) such as ChatGPT. She compared real-time retrieval tools like Microsoft Bing with LLMs, showing how each has strengths and limitations. Neena also demonstrated practical applications of AI for investment analysis, portfolio construction, and education, while noting the importance of prompt engineering and human expertise in guiding these systems responsibly.

The lively discussion underscored both the opportunities and challenges of AI—its ability to accelerate breakthroughs in healthcare and finance, while also raising important questions of ethics, accuracy, and regulation.
https://zurl.co/cvbV2

Veda Financial | September 2025 WIN Women’s Initiative Network – Meeting on Artificial Intelligence Date: September 7, 2025 Organized by Shaku Nitturkar S

09/10/2025

Wall Street’s Cinderella Story: The Trillion-Dollar Turnaround No One Saw Coming

Every so often, a company written off as “too old” or “too slow” surprises everyone. This week it was Oracle (ORCL) — soaring nearly 50% in just days, adding close to $285 billion in market value, and suddenly knocking on the door of the trillion-dollar club.

1. Cloud infrastructure revenue projected to grow 77% YoY
2. $455B in contracted backlog, expected to pass $500B
3. Multi-billion-dollar AI deals with OpenAI, Meta, Nvidia, and xAI

Despite missing earnings estimates, Oracle’s forward contracts and AI exposure stole the show.

Takeaway: Markets reward growth visibility. A massive backlog plus AI positioning turned Oracle from “legacy laggard” to “Cinderella stock.”

What other underdogs could be waiting for their turn at the trillion-dollar ball? https://zurl.co/3g0dW

The Belle of the Ball          Veda Financial | September 2025 Every so often, the market crowns a new Cinderella. A company wr

08/28/2025

Is Jensen Huang the biggest bargaining CHIP in the trade war between the U.S. and China? The Nvidia CEO seems to have found a second calling in the role of accidental diplomat, playing both sides of the fence in Washington and Beijing at the height of export restrictions.

The big win - in a rare policy reversal — the U.S. granted Nvidia new export licenses, unlocking billions in potential chip sales to China while easing tensions in a volatile trade environment.

What is amazing is not just the business chess playing, but how one company — and one CEO — became central to the world’s most sensitive geopolitical negotiation.

In a moment when chips power everything from AI to defense, Huang has gone from techie to shaping the balance of global power.

Hope India finds a way to negotiate something similar — carving out its own space in the global tech and trade conversation!

More deets here - https://zurl.co/58GJ6

08/27/2025

How to Invest When Volatility Really Worries You: Those who know me know I really like Market-Linked Notes as a hybrid instrument that combines the growth aspect of stocks with the downside protection of bonds. It's like equities and fixed income got together and had the perfect, balanced child!

Markets can feel like a roller coaster. Headlines about wars, elections, inflation, or recession can make investors second-guess where to put their money. One solution: Market-Linked Notes.

These structured products offer:
Upside participation in market growth
Downside protection similar to bonds

Example: In 2020, Morgan Stanley issued a note with 175% of market gains and protection from the first 20% of losses. It just matured, doubling the original investment value. Investors who stayed the course came out ahead without taking on the full risk of stocks.

Other structured products worth considering:

Principal-Protected Notes – safeguard your original investment while offering growth potential
Fixed-Rate Notes – steady, predictable income regardless of market swings

The takeaway: you don’t have to sit on the sidelines just because volatility makes you uneasy. Structured products let you stay invested—with defined protections in place.

For more info: https://zurl.co/mQBbj

This is for informational purposes only and not investment advice. All investments carry risk. Past performance is not a guarantee of future results.

This link will take you to a page that’s not on LinkedIn

08/27/2025

Tariff-Resistant Investing: Where to Find Shelter in a Trade Storm

With tariff policies once again in the spotlight, investors are grappling with how to navigate markets affected by global trade tensions—especially with upcoming tariff announcements targeting China, Europe, and parts of Asia.
Key Categories and Strategies Likely to Be Less Susceptible to Tariffs:
• Domestic-focused companies: Especially those that earn most revenue within the U.S., including regional banks, utilities, and localized retailers.
• Service-based industries: Sectors like software, healthcare, and education that don’t rely on international goods trade.
• Large-cap quality stocks: Firms with scale, strong supplier/customer negotiating power, and pricing flexibility.
• Capital goods sector: Well positioned due to strong pricing power and the ability to pass on costs.
• Companies with mitigation strategies, including:
• Ability to raise prices
• Currency hedging
• Redirection of products to untariffed markets
• Inventory stockpiling
• Diversified global supply chains

Summary:
While no stocks are completely immune, companies with domestic focus, service-driven revenue, or strong operational flexibility can better withstand tariffs. Staying focused on large-cap, high-quality companies with pricing power and mitigation strategies offers a smart path through trade-related uncertainty.

08/20/2025

🚀 Strategic Reinvestments Drive Strong Mid-Year Portfolio Growth

As we enter Q3 2025, markets are proving resilient, with portfolio performance strengthening after a slow Q1. At Veda Financial, our disciplined reinvestment strategy continues to fuel growth across high-potential sectors.

🔹 Defense: +30% YTD growth amid rising global demand
🔹 Artificial Intelligence: Record-breaking funding in Q2 2025
🔹 Tech, Semiconductors & Cybersecurity: Strong, diversified returns

Looking ahead, we remain focused on balanced growth, risk management, and tax efficiency—with new tools coming soon to help clients stay aligned with their goals.

👉 Read the full article here: https://www.vedafinancial.com/blogs/post/strategic-reinvestments-drive-strong-mid-year-portfolio-growth

08/20/2025

From R&D to Exits: OBBBA’s Impact on Founders, Startups, and Early Investors: On August 19, 2025, TiE SoCal hosted an insightful panel discussion on the One Big Beautiful Bill Act (OBBBA)—a tax reform designed to accelerate innovation, strengthen the U.S. startup ecosystem, and improve returns for early investors.The discussion featured expert insights from Azad Virk, Shashi Tripathi, Jay Nitturkar, and Ravi Bhagwan, and was moderated by Ruchi Lamba. Together, the panel unpacked how OBBBA changes the landscape for entrepreneurs and investors alike.
⸻
Key Learnings from the Discussion

1. QSBS Reform – Encouraging Startup Investment Through Tax-Free Gains
OBBBA expands and modernizes the Qualified Small Business Stock (QSBS) program, which allows founders and investors in small C-corporations to exclude capital gains when selling their shares.
• QSBS applies only to stock in a C-corporation (not SAFEs, notes, or LLC/S-corps).
• Holding period for exclusions is shortened:
• 3 years → 50% exclusion
• 4 years → 75% exclusion
• 5 years → 100% exclusion
• Benefits can be multiplied (“stacked”) across founders, spouses, and trusts.
• The company must have under $75M in gross assets at issuance (up from $50M, indexed to inflation).

2. Tax Incentives for Innovation and Growth – Boosting Startup Cash Flow
The bill restores and extends provisions that give startups faster deductions, stronger balance sheets, and more flexibility in scaling.
• R&D expensing: Full deduction in the year costs are incurred (reversing the 5-year amortization rule).
• Net Operating Losses (NOLs): Carryforwards can be used more flexibly, making startups more attractive for acquisition.
• Bonus depreciation: 100% write-offs extended for equipment and technology investments.
• Real estate cost segregation: Faster depreciation on facilities, freeing up capital for growth.

3. Impact on Startups and Investors – A More Attractive U.S. Ecosystem
Taken together, these reforms reduce risk for investors, improve liquidity, and make early-stage ventures more fundable.
• Investors gain earlier access to tax-advantaged exits and higher effective returns.
• Startups benefit from stronger cash flow and greater investor interest.
• The U.S. startup ecosystem becomes more appealing to both domestic and international capital.

⸻

Summary
The One Big Beautiful Bill Act is designed to stimulate entrepreneurship by lowering the tax burden on startup investment, restoring favorable treatment of R&D, and accelerating deductions for growth. For founders, this means easier fundraising and better liquidity. For investors, it provides faster, larger tax benefits on successful exits. Collectively, it marks a significant step toward reinforcing the U.S. as the global hub for innovation and venture capital.

08/15/2025

Reversing Cancer, But Not the Markets: In an amazing breakthrough, scientists are now learning not to kill cancer cells, but to reprogram them back into healthy ones. KAIST’s new “reversion therapy” turns malignant colon cancer cells into normal-like tissue, a discovery that could reshape oncology. However, the irony is that for all the promise of discoveries like this, CRISPR gene editing, and AI-driven drug discovery, the biotech sector is still lagging the markets—with the XBI down 5.5% YTD vs. a +8.7% gain for the S&P 500.
The gap is a reminder that science and markets run on different clocks. In the lab, we can make history in a decade. On Wall Street, investors want results in a quarter. Long R&D cycles, high trial failure rates, and regulatory uncertainty mean even the most transformative therapies can take years to translate into returns.

Here’s a deeper look at the technology and and my thoughts on why it’s not yet showing up on the market scoreboard.
https://zurl.co/auyHj

08/15/2025

📈 Navigating Market Volatility with a Long-Term Perspective

Market ups and downs can be unsettling — but short-term fluctuations often mask strong underlying fundamentals.
History shows that patience, discipline, and a long-term view remain the most effective tools for building wealth.

🔹 Markets trend upward over time despite temporary setbacks.
🔹 Trying to “time” the market can cost you significant returns.
🔹 Staying invested helps capture the best days that drive long-term growth.

Instead of reacting to every headline, focus on your long-term goals. Time is the best reducer of volatility, and investors who stay the course are often rewarded.

📌 Every investor’s situation is unique — if you’re feeling uncertain, consider speaking with a trusted advisor.

👉 Read the full article:

Dear clients, investors and friends,   Recent market developments have sparked discussions and raised concerns among investors. Many short-term m

05/14/2025

📈 **Tariff-Resistant Investing: Where to Find Shelter in a Trade Storm** 🌪️💰
With tariff policies once again in the spotlight, investors are grappling with how to navigate markets affected by global trade tensions—especially with upcoming tariff announcements targeting China, Europe, and parts of Asia.

**Key Categories and Strategies Likely to Be Less Susceptible to Tariffs:**
**• Domestic-focused companies:** Especially those that earn most revenue within the U.S., including regional banks, utilities, and localized retailers.
**• Service-based industries:** Sectors like software, healthcare, and education that don’t rely on international goods trade.
**• Large-cap quality stocks:** Firms with scale, strong supplier/customer negotiating power, and pricing flexibility.
**• Capital goods sector:** Well positioned due to strong pricing power and the ability to pass on costs.
**• Companies with mitigation strategies**, including:
- Ability to raise prices
- Currency hedging
- Redirection of products to untariffed markets
- Inventory stockpiling
- Diversified global supply chains

Summary:
While no stocks are completely immune, companies with domestic focus, service-driven revenue, or strong operational flexibility can better withstand tariffs. Staying focused on large-cap, high-quality companies with pricing power and mitigation strategies offers a smart path through trade-related uncertainty. 📊🔒